We are live on !
Find out more
Optimal Asset Management Portfolio holdings
AUM
$800M
Turnover
4.2%
1-Year Est. Return
28.13%
This Fund
S&P 500
This Quarter Est. Return
-0.59%
1 Year Est. Return
+28.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$800M
AUM Growth
-$44.7M
(-5.3%)
Cap. Flow
-$41.2M
Cap. Flow % of AUM
Cap. Flow %
-5.15%
Top 10 Holdings %
Top 10 Hldgs %
11.56%
Holding
357
New
5
Increased
262
Reduced
12
Closed
10
Avg Time Held
Equity + Options
1.4
years
Top 10 Avg Time Held
Equity + Options
0.7
years
Top 20 Avg Time Held
Equity + Options
0.8
years
Avg Time Held Equity only
1.4
years
Top 10 Avg Time Held Equity only
0.7
years
Top 20 Avg Time Held Equity only
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$2.07M |
| 2 |
Analog Devices
ADI
|
+$848K |
| 3 |
RTX Corp
RTX
|
+$750K |
| 4 |
Organon & Co
OGN
|
+$209K |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$101K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$8.09M |
| 2 |
Target
TGT
|
+$7.49M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$6.6M |
| 4 |
Liberty Broadband Class C
LBRDK
|
+$4.49M |
| 5 |
Warner Bros
WBD
|
+$3.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.18% |
| 2 | Healthcare | 14.55% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 11.45% |
| 5 | Industrials | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Copart
CPRT
$29.5B
| $4.37M | 0.55% |
126,076
+164
| +0.1% | +$5.86K |
2019 Q4
7 quarters
|
|
52
Sempra
SRE
$52B
| $4.35M | 0.54% |
68,740
+112
| +0.2% | +$7.39K |
2019 Q4
7 quarters
|
|
53
C.H. Robinson
CHRW
$15.6B
| $4.33M | 0.54% |
49,734
+123
| +0.2% | +$11.1K |
2019 Q4
7 quarters
|
|
54
Amazon
AMZN
$2.88T
| $4.29M | 0.54% |
26,120
+80
| +0.3% | +$13.8K |
2019 Q4
7 quarters
|
|
55
Bio-Rad Laboratories Class A
BIO
$9.9B
| $4.2M | 0.52% |
5,626
+13
| +0.2% | +$9.7K |
2019 Q4
7 quarters
|
|
56
Keurig Dr Pepper
KDP
$49.5B
| $4.16M | 0.52% |
121,703
+264
| +0.2% | +$9.23K |
2020 Q3
4 quarters
|
|
57
Revvity
RVTY
$17.2B
| $4.15M | 0.52% |
23,928
+9
| +0% | +$1.59K |
2020 Q2
5 quarters
|
|
58
Lincoln Electric
LECO
$15.3B
| $4.11M | 0.51% |
31,927
+20
| +0.1% | +$2.72K |
2020 Q1
6 quarters
|
|
|
BKI
59
DELISTED
Black Knight, Inc. Common Stock
BKI
| $4.09M | 0.51% |
56,839
+172
| +0.3% | +$13.2K |
2019 Q4
7 quarters
|
|
60
Newmont
NEM
$118B
| $4.07M | 0.51% |
74,976
+226
| +0.3% | +$13.3K |
2019 Q4
7 quarters
|
|
61
Danaher
DHR
$164B
| $4.04M | 0.5% |
14,960
+39
| +0.3% | +$10.6K |
2019 Q4
7 quarters
|
|
62
Dentsply Sirona
XRAY
$1.83B
| $4M | 0.5% |
68,883
+186
| +0.3% | +$11.5K |
2019 Q4
7 quarters
|
|
63
MSCI
MSCI
$47.1B
| $3.98M | 0.5% |
6,544
+14
| +0.2% | +$8.55K |
2019 Q4
7 quarters
|
|
64
DexCom
DXCM
$31.1B
| $3.97M | 0.5% |
29,040
+88
| +0.3% | +$11.1K |
2019 Q4
7 quarters
|
|
65
Archer Daniels Midland
ADM
$34.7B
| $3.97M | 0.5% |
66,106
+125
| +0.2% | +$7.5K |
2019 Q4
7 quarters
|
|
66
VeriSign
VRSN
$28.1B
| $3.86M | 0.48% |
18,808
+8
| +0% | +$1.75K |
2021 Q1
2 quarters
|
|
67
Pfizer
PFE
$165B
| $3.82M | 0.48% |
88,766
| – | – |
2019 Q4
7 quarters
|
|
68
D.R. Horton
DHI
$39.5B
| $3.81M | 0.48% |
45,409
+154
| +0.3% | +$14.2K |
2019 Q4
7 quarters
|
|
69
NetApp
NTAP
$35.6B
| $3.81M | 0.48% |
42,477
+36
| +0.1% | +$3.04K |
2019 Q4
7 quarters
|
|
70
General Motors
GM
$72.5B
| $3.74M | 0.47% |
70,894
+147
| +0.2% | +$7.81K |
2019 Q4
7 quarters
|
|
71
DocuSign
DOCU
$15.1B
| $3.73M | 0.47% |
14,506
+44
| +0.3% | +$12.7K |
2020 Q2
5 quarters
|
|
72
Regeneron Pharmaceuticals
REGN
$98.8B
| $3.71M | 0.46% |
6,137
+10
| +0.2% | +$6.21K |
2019 Q4
7 quarters
|
|
73
Hormel Foods
HRL
$12.2B
| $3.67M | 0.46% |
89,604
+188
| +0.2% | +$8.48K |
2019 Q4
7 quarters
|
|
74
Advanced Micro Devices
AMD
$876B
| $3.63M | 0.45% |
35,316
+91
| +0.3% | +$9.3K |
2019 Q4
7 quarters
|
|
75
McDonald's
MCD
$192B
| $3.63M | 0.45% |
15,062
+23
| +0.2% | +$5.49K |
2019 Q4
7 quarters
|
|
Similar funds
Optimal Asset Management's Q3 2021 Portfolio in Review
As of Q3 2021, Optimal Asset Management held 357 positions worth $800M, down 5.3% from $845M the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Optimal Asset Management withdrew a net $41.2M in Q3 2021, closing 10 positions and reducing 12 holdings. Its most notable exit was Comcast, an estimated $8.09M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Optimal Asset Management opened a new position in AstraZeneca worth $2.13M.
- Optimal Asset Management's largest Q3 2021 buy was AstraZeneca: 17,751 shares worth $2.13M.
- Optimal Asset Management added most to Schwab Short-Term US Treasury ETF in Q3 2021, an estimated $101K increase.
- Optimal Asset Management's biggest Q3 2021 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $2.05M.
- Optimal Asset Management fully exited Comcast in Q3 2021, selling an estimated $8.09M.
- Optimal Asset Management's ten largest holdings make up 12% of its $800M portfolio in Q3 2021.
- Optimal Asset Management opened 5 new positions and closed 10 in Q3 2021.
- Optimal Asset Management's portfolio value fell 5.3% quarter-over-quarter to $800M.
Based on Optimal Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.